Navigation Links
MDs' reactions to pharma marketing influenced by brand, side effects: Management Insights
Date:12/10/2007

A study of pharmaceutical companies marketing to physicians shows that doctors are most influenced by brand preference and marketing that addresses the problems of drugs with many side effects, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS).

Management Insights, a regular feature of the journal, is a digest of important research in business, management, operations research, and management science. It appears in every issue of the monthly journal.

The Debate on Influencing Doctors Decisions: Are Drug Characteristics the Missing Link? is by Sriram Venkataraman of Emory University and Stefan Stremersch of Duke University.

Decision making by physicians on patients treatment has come under increased public scrutiny, with debate on the effects of marketing actions of pharmaceutical firms toward physicians and their impact on physician prescription behavior. Some scholars find a strong and positive influence of marketing actions, some find only moderate effects, and others even find negative effects.

Debate is also mounting on the role of other influencers (such as patient requests) in physician decision making, both on prescriptions and sample dispensing.

In their Management Science paper, Venkataraman and Stremersch argue that one factor that may tip the balance in this debate is the role of drug characteristics, such as a drugs effectiveness and a drugs side effects. Using a unique data set, they show that marketing effortsoperationalized as detailing and symposium meetings of firms to physiciansand patient requests do affect physician decision making differentially across brands.

They also find that the responsiveness of physicians decision making to marketing efforts and patient requests depends upon the drugs effectiveness and side effects.

The current issue of Management Insights is available at http://mansci.journal.informs.org/cgi/reprint/53/11/iv. The full papers associated with the Insights are available to Management Science subscribers. Individual papers can be purchased at http://institutions.informs.org. Additional issues of Management Insights can be accessed at http://mansci.pubs/informs/org/.

The Insights in the current issue are:

  • Managerial Turnover and Strategic Change by Dirk Sliwka
  • Choosing Among Living-Donor and Cadaveric Livers by Oguzhan Alagoz, Lisa M. Maillart, Andrew J. Schaefer, Mark S. Roberts
  • Template Use and the Effectiveness of Knowledge Transfer by Robert J. Jensen, Gabriel Szulanski
  • Coherence and Consistency of Investors Probability Judgments by David V. Budescu, Ning Du
  • Probability Elicitation, Scoring Rules, and Competition Among Forecasters by Kenneth C. Lichtendahl Jr., Robert L. Winkler
  • Simulation of Coherent Risk Measures Based on Generalized Scenarios by Vadim Lesnevski, Barry L. Nelson, Jeremy Staum
  • The Effects of Statistical Information on Risk and Ambiguity Attitudes, and on Rational Insurance Decisions by Peter P. Wakker, Danille R. M. Timmermans, Irma Machielse
  • Final-Offer Arbitration and Risk Aversion in Bargaining by Eran Hanany, D. Marc Kilgour, Yigal Gerchak
  • Convertible Bond Underpricing: Renegotiable Covenants, Seasoning, and Convergence by Alex W. H. Chan, Nai-fu Chen
  • Optimal Feature Advertising Design Under Competitive Clutter by Rik Pieters, Michel Wedel, Jie Zhang


'/>"/>

Contact: Barry List
barry.list@informs.org
443-757-3560
Institute for Operations Research and the Management Sciences
Source:Eurekalert

Related medicine news :

1. London School of Hygiene to play key role in global collaboration on adverse drug reactions
2. DOCTORS OPPOSE MARYLAND VACCINE ROUNDUP: Expect Dangerous Reactions When Children Are Treated Like Cattle
3. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
4. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
5. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
10. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
11. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... April 26, 2017 , ... The ... Excellence upon National Registry of Emergency Medical Technicians and welcomes this ... said Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: